Cargando…

Light chain deposition disease involving kidney and liver in a patient with IgD myeloma

BACKGROUND: IgD multiple myeloma (MM) is a rare subtype of MM and light chain deposition disease (LCDD) outside the kidney is also a rare and has scarcely been reported. We report herein the details of the first reported case of LCDD involving the kidney and liver co-occurring with IgD myeloma. CASE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsushima, Takafumi, Suzuki, Tomo, Terao, Toshiki, Miura, Daisuke, Narita, Kentaro, Takeuchi, Masami, Shimuzu, Akira, Matsue, Kosei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824927/ https://www.ncbi.nlm.nih.gov/pubmed/33485303 http://dx.doi.org/10.1186/s12882-021-02246-9

Ejemplares similares

Social frailty predicts worse outcomes in patients with multiple myeloma: A novelty in an old approach
por: Terao, Toshiki, et al.
Publicado: (2020)

Quantification of measurable residual disease in patients with multiple myeloma based on the IMWG response criteria
por: Narita, Kentaro, et al.
Publicado: (2021)

Association between serum erythropoietin levels and renal reversibility in patients with renal impairment from multiple myeloma
por: Kobayashi, Hiroki, et al.
Publicado: (2020)

Multiple myeloma with t(11;14)‐associated immature phenotype has lower CD38 expression and higher BCL2 dependence
por: Kitadate, Akihiro, et al.
Publicado: (2021)

Association of loss of spleen visualization on whole-body diffusion-weighted imaging with prognosis and tumor burden in patients with multiple myeloma
por: Terao, Toshiki, et al.
Publicado: (2021)

Letermovir Administration to Prevent Cytomegalovirus Reactivation Is the Potential Risk of Chronic Graft-Versus-Host Disease in Patients Who Received Haploidentical Stem-Cell Transplantation With Post-Transplant Cyclophosphamide
por: Terao, Toshiki, et al.
Publicado: (2021)

Antibody response to COVID-19 vaccine in 130 recipients of hematopoietic stem cell transplantation
por: Tsushima, Takafumi, et al.
Publicado: (2022)

Baseline total lesion glycolysis combined with interim positron emission tomography‐computed tomography is a robust predictor of outcome in patients with peripheral T‐cell lymphoma
por: Kitadate, Akihiro, et al.
Publicado: (2020)

Impaired Antibody Response Following the Second Dose of the BNT162b2 Vaccine in Patients With Myeloproliferative Neoplasms Receiving Ruxolitinib
por: Ikeda, Daisuke, et al.
Publicado: (2022)

Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma
por: Terao, Toshiki, et al.
Publicado: (2022)

Humoral Response to the Third-Dose COVID-19 Vaccination in Patients with Hematological Malignancy
por: Ikeda, Daisuke, et al.
Publicado: (2022)

Abnormal heavy/light chain ratio after treatment is associated with shorter survival in patients with IgA myeloma
por: Suehara, Yasuhito, et al.
Publicado: (2017)

Antibody response to COVID-19 vaccination in patients with lymphoma
por: Narita, Kentaro, et al.
Publicado: (2022)

N-terminal pro-brain natriuretic peptide reflects both left ventricular diastolic dysfunction and myeloma-related renal insufficiency and robustly predicts mortality in patients with symptomatic multiple myeloma
por: Abe, Yoshiaki, et al.
Publicado: (2019)

Follow-up of IgD-κ multiple myeloma by monitoring free light chains and total heavy chain IgD: A case report
por: De Santis, Elena, et al.
Publicado: (2016)

Anaplastic morphology in IgD multiple myeloma
por: Roldán Galiacho, Verónica, et al.
Publicado: (2023)

Brain toxoplasmosis after HLA haploidentical transplantation for acute myeloid leukemia
por: Tsushima, Takafumi, et al.
Publicado: (2022)

Lambda Light Chain Non-crystalline Proximal Tubulopathy with IgD Lambda Myeloma
por: Kishi, Seiji, et al.
Publicado: (2018)

AL Amyloidosis in a Patient with IgD Myeloma
por: Rafik, Hicham, et al.
Publicado: (2020)

Diagnosis of intravascular large B cell lymphoma: novel insights into clinicopathological features from 42 patients at a single institution over 20 years
por: Matsue, Kosei, et al.
Publicado: (2019)

Bone marrow infiltration pattern in patients with intravascular large B‐cell lymphoma diagnosed by random skin biopsy
por: Matsue, Kosei, et al.
Publicado: (2020)

P1547: CLINICAL CHARACTERISTICS OF PATIENTS WITH PROLONGED VIRAL SHEDDING OF OMICRON VARIANT IN HAEMATOLOGICAL DISEASE
por: Ikeda, Daisuke, et al.
Publicado: (2023)

IgD myeloma/immunoblastic lymphoma cells expressing cytokeratin.
por: Sewell, H. F., et al.
Publicado: (1986)

IgD Multiple Myeloma Paraproteinemia as a Cause of Myositis
por: Colombo, I., et al.
Publicado: (2010)

Aggressive FLC Escape in a Patient with IgD Myeloma
por: Farges, Cédric, et al.
Publicado: (2015)

Clinical characteristics and survival of patients with IgD multiple myeloma
por: Li, Yi, et al.
Publicado: (2021)

Detection of intracellular IgD using flow cytometry could be a novel and supplementary method to diagnose IgD multiple myeloma
por: Wang, Wei, et al.
Publicado: (2018)

P1137: COMBINED METABOLIC HETEROGENEITY AND TOTAL LESION GLYCOLYSIS FROM PET-CT IMPROVES THE PROGNOSTIC STRATIFICATION IN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA
por: Ikeda, Daisuke, et al.
Publicado: (2023)

IgD myeloma indicated by plasma cells in the peripheral blood and massive pleural effusion
por: Natori, Kazuhiko, et al.
Publicado: (2008)

Clinical and immunological characteristics of prolonged SARS-CoV-2 Omicron infection in hematologic disease
por: Ikeda, Daisuke, et al.
Publicado: (2023)

Immune response to SARS-CoV-2 vaccination among renal replacement therapy patients with CKD: a single-center study
por: Matsunami, Masatoshi, et al.
Publicado: (2021)

N-glycosylation of serum proteins for the assessment of patients with IgD multiple myeloma
por: Chen, Jie, et al.
Publicado: (2017)

OCCURRENCE OF SURFACE IgM, IgD, AND FREE LIGHT CHAINS ON HUMAN LYMPHOCYTES
por: Fu, Shu Man, et al.
Publicado: (1974)

Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN)
por: Liu, Jin, et al.
Publicado: (2020)

Physiology of IgD. IV. Enhancement of antibody production in mice bearing IgD-secreting plasmacytomas
Publicado: (1984)

Clinical characteristics and outcomes of IgD myeloma: experience across UK national trials
por: Agbuduwe, Charles, et al.
Publicado: (2022)

Expression of IgD by murine lymphocytes. Loss of surface IgD indicates maturation of memory B cells
Publicado: (1978)

Physiology of IgD. VI. Transfer of the immunoaugmenting effect of IgD with T delta-containing helper cell populations
Publicado: (1985)

Improved survival outcomes and relative youthfulness of multiple myeloma patients with t(4;14) receiving novel agents are associated with poorer performance of the revised international staging system in a real aging society
por: Abe, Yoshiaki, et al.
Publicado: (2019)

Prevalence and Clinical Outcome of Omicron Breakthrough Infection in Patients With Hematologic Disease: A Prospective Observational Cohort Study
por: Narita, Kentaro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kvbapl54un5fsqhiu2q7u57asc